Cargando…

Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models

INTRODUCTION: Multi-marker molecular assays have impacted management of early stage breast cancer, facilitating adjuvant chemotherapy decisions. We generated prognostic models that incorporate protein-based molecular markers and clinico-pathological variables to improve survival prediction. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parisi, Fabio, González, Ana M, Nadler, Yasmine, Camp, Robert L, Rimm, David L, Kluger, Harriet M, Kluger, Yuval
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096952/ https://www.ncbi.nlm.nih.gov/pubmed/20809974 http://dx.doi.org/10.1186/bcr2633

Ejemplares similares

Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer
por: Nadler, Yasmine, et al.
Publicado: (2008)

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma
por: Giesen, Eva, et al.
Publicado: (2014)

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors
por: Aziz, Saadia A, et al.
Publicado: (2013)

MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors
por: Shuch, Brian, et al.
Publicado: (2015)

Impact of healthcare worker shift scheduling on workforce preservation during the COVID-19 pandemic
por: Kluger, Dan M., et al.
Publicado: (2020)

VDA, a Method of Choosing a Better Algorithm with Fewer Validations
por: Strino, Francesco, et al.
Publicado: (2011)

Characterizing disease states from topological properties of transcriptional regulatory networks
por: Tuck, David P, et al.
Publicado: (2006)

SIMVI reveals intrinsic and spatial-induced states in spatial omics data
por: Dong, Mingze, et al.
Publicado: (2023)

TrAp: a tree approach for fingerprinting subclonal tumor composition
por: Strino, Francesco, et al.
Publicado: (2013)

Integrated Analysis of Tumor Samples Sheds Light on Tumor Heterogeneity
por: Parisi, Fabio, et al.
Publicado: (2012)

The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization
por: Kluger, Harriet M, et al.
Publicado: (2007)

Drug targets and predictive biomarkers in the management of metastatic melanoma
por: Thumar, Jaykumar, et al.
Publicado: (2012)

Cytomegalic Inclusion-Body Disease: Clinico-Pathological Conference
por: Lloyd, O. C.
Publicado: (1965)

Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy
por: Martinez-Morilla, Sandra, et al.
Publicado: (2020)

Picking ChIP-seq peak detectors for analyzing chromatin modification experiments
por: Micsinai, Mariann, et al.
Publicado: (2012)

Arpeggio: harmonic compression of ChIP-seq data reveals protein-chromatin interaction signatures
por: Stanton, Kelly Patrick, et al.
Publicado: (2013)

Interactions with RNA direct the Polycomb group protein SCML2 to chromatin where it represses target genes
por: Bonasio, Roberto, et al.
Publicado: (2014)

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance
por: Schoenfeld, David A., et al.
Publicado: (2022)

Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma
por: Wong, Pok Fai, et al.
Publicado: (2019)

Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells
por: Zito, Christopher R., et al.
Publicado: (2012)

Zero-preserving imputation of single-cell RNA-seq data
por: Linderman, George C., et al.
Publicado: (2022)

Vascularity of primary and metastatic renal cell carcinoma specimens
por: Aziz, Saadia A, et al.
Publicado: (2013)

Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade
por: Vathiotis, Ioannis A., et al.
Publicado: (2022)

A Tissue Quality Index – an Intrinsic Control for Measurement of Effects of Pre-analytical Variables on FFPE Tissue
por: Neumeister, Veronique M., et al.
Publicado: (2014)

Targeting Innate Immunity to Treat Cancer
por: Austin, Matthew, et al.
Publicado: (2020)

PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases
por: Jilaveanu, L.B., et al.
Publicado: (2014)

Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure
por: Qu, Rihao, et al.
Publicado: (2022)

Systemic Immunotherapy for the Treatment of Brain Metastases
por: Cohen, Justine V., et al.
Publicado: (2016)

Unraveling condition specific gene transcriptional regulatory networks in Saccharomyces cerevisiae
por: Kim, Hyunsoo, et al.
Publicado: (2006)

Clinico-pathological and prognostic overview of metastasizing ameloblastoma: An overview of the systematic reviews
por: Sarode, Gargi, et al.
Publicado: (2023)

Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association
por: Mehta, Anurag, et al.
Publicado: (2019)

Anti-PD-1 Therapy-Associated Perforating Colitis
por: Celli, Romulo, et al.
Publicado: (2018)

Agonistic CD40 Antibodies in Cancer Treatment
por: Djureinovic, Dijana, et al.
Publicado: (2021)

Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies
por: Parisi, Fabio, et al.
Publicado: (2011)

Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases
por: Schoenfeld, David A, et al.
Publicado: (2023)

Inter- and intra-combinatorial regulation by transcription factors and microRNAs
por: Zhou, Yiming, et al.
Publicado: (2007)

Relationship between gene co-expression and probe localization on microarray slides
por: Kluger, Yuval, et al.
Publicado: (2003)

Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
por: Elfiky, Aymen A, et al.
Publicado: (2011)

Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
por: Aziz, Saadia A, et al.
Publicado: (2014)

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF(WT) melanoma cells
por: Halaban, Ruth, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gps462521m5t27sga6luort1r9